Literature DB >> 20825408

Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucose.

Arti Dhar1, Indu Dhar, Kaushik M Desai, Lingyun Wu.   

Abstract

BACKGROUND AND
PURPOSE: Endothelial dysfunction is a feature of hypertension and diabetes. Methylglyoxal (MG) is a reactive dicarbonyl metabolite of glucose and its levels are elevated in spontaneously hypertensive rats and in diabetic patients. We investigated if MG induces endothelial dysfunction and whether MG scavengers can prevent endothelial dysfunction induced by MG and high glucose concentrations. EXPERIMENTAL APPROACH: Endothelium-dependent relaxation was studied in aortic rings from Sprague-Dawley rats. We also used cultured rat aortic and human umbilical vein endothelial cells. The MG was measured by HPLC and Western blotting and assay kits were used. KEY
RESULTS: Incubation of aortic rings with MG (30 µM) or high glucose (25 mM) attenuated endothelium-dependent, acetylcholine-induced relaxation, which was restored by two different MG scavengers, aminoguanidine (100 µM) and N-acetyl cysteine (NAC) (600 µM). Treatment of cultured endothelial cells with MG or high glucose increased cellular MG levels, effects prevented by aminoguanidine and NAC. In cultured endothelial cells, MG and high glucose reduced basal and bradykinin-stimulated nitric oxide (NO) production, cGMP levels, and serine-1177 phosphorylation and activity of endothelial NO synthase (eNOS), without affecting threonine-495 and Akt phosphorylation or total eNOS protein. These effects of MG and high glucose were attenuated by aminoguanidine or NAC. CONCLUSIONS AND IMPLICATIONS: Our results show for the first time that MG reduced serine-1177 phosphorylation, activity of eNOS and NO production. MG caused endothelial dysfunction similar to that induced by high glucose. Specific and safe MG scavengers have potential to prevent endothelial dysfunction induced by MG and high glucose concentrations.
© 2010 The Authors. British Journal of Pharmacology © 2010 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20825408      PMCID: PMC3010587          DOI: 10.1111/j.1476-5381.2010.01017.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  Selective inhibition of the inducible nitric oxide synthase by aminoguanidine.

Authors:  T P Misko; W M Moore; T P Kasten; G A Nickols; J A Corbett; R G Tilton; M L McDaniel; J R Williamson; M G Currie
Journal:  Eur J Pharmacol       Date:  1993-03-16       Impact factor: 4.432

Review 2.  Cyclic GMP synthesis and function.

Authors:  S A Waldman; F Murad
Journal:  Pharmacol Rev       Date:  1987-09       Impact factor: 25.468

3.  Isolation of rat aortic endothelial cells by primary explant techniques and their phenotypic modulation by defined substrata.

Authors:  P G McGuire; R W Orkin
Journal:  Lab Invest       Date:  1987-07       Impact factor: 5.662

4.  cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue.

Authors:  A Papapetropoulos; A Cziraki; J W Rubin; C D Stone; J D Catravas
Journal:  J Cell Physiol       Date:  1996-05       Impact factor: 6.384

5.  Alagebrium attenuates acute methylglyoxal-induced glucose intolerance in Sprague-Dawley rats.

Authors:  Arti Dhar; Kaushik M Desai; Lingyun Wu
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

6.  Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

Authors:  K K Griendling; C A Minieri; J D Ollerenshaw; R W Alexander
Journal:  Circ Res       Date:  1994-06       Impact factor: 17.367

7.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

8.  Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.

Authors:  J A Corbett; R G Tilton; K Chang; K S Hasan; Y Ido; J L Wang; M A Sweetland; J R Lancaster; J R Williamson; M L McDaniel
Journal:  Diabetes       Date:  1992-04       Impact factor: 9.461

9.  Methylglyoxal: a stimulus to neutrophil oxygen radical production in chronic renal failure?

Authors:  Richard A Ward; Kenneth R McLeish
Journal:  Nephrol Dial Transplant       Date:  2004-05-18       Impact factor: 5.992

10.  The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins.

Authors:  T W Lo; T Selwood; P J Thornalley
Journal:  Biochem Pharmacol       Date:  1994-11-16       Impact factor: 5.858

View more
  37 in total

1.  Ameliorating Methylglyoxal-Induced Progenitor Cell Dysfunction for Tissue Repair in Diabetes.

Authors:  Hainan Li; Megan O'Meara; Xiang Zhang; Kezhong Zhang; Berhane Seyoum; Zhengping Yi; Randal J Kaufman; Terrence J Monks; Jie-Mei Wang
Journal:  Diabetes       Date:  2019-03-18       Impact factor: 9.461

2.  New dinitrosyl iron complexes bound with physiologically active dipeptide carnosine.

Authors:  Konstantin B Shumaev; Olga V Kosmachevskaya; Elvira I Nasybullina; Sergey V Gromov; Alexander A Novikov; Alexey F Topunov
Journal:  J Biol Inorg Chem       Date:  2016-11-22       Impact factor: 3.358

3.  LR-90 prevents methylglyoxal-induced oxidative stress and apoptosis in human endothelial cells.

Authors:  James L Figarola; Jyotsana Singhal; Samuel Rahbar; Sanjay Awasthi; Sharad S Singhal
Journal:  Apoptosis       Date:  2014-05       Impact factor: 4.677

4.  MiR-27b augments bone marrow progenitor cell survival via suppressing the mitochondrial apoptotic pathway in Type 2 diabetes.

Authors:  Hainan Li; Jenny Liu; Yihan Wang; Zhiyao Fu; Maik Hüttemann; Terrence J Monks; Alex F Chen; Jie-Mei Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-07-11       Impact factor: 4.310

5.  Aminoguanidine reduces diabetes-associated cardiac fibrosis.

Authors:  Fernando Magdaleno; Chuck Christopher Blajszczak; Claudia Lisette Charles-Niño; Alma Marlene Guadrón-Llanos; Alan Omar Vázquez-Álvarez; Alejandra Guillermina Miranda-Díaz; Natalia Nieto; María Cristina Islas-Carbajal; Ana Rosa Rincón-Sánchez
Journal:  Exp Ther Med       Date:  2019-08-20       Impact factor: 2.447

Review 6.  Alagebrium and Complications of Diabetes Mellitus.

Authors:  Cigdem Toprak; Semra Yigitaslan
Journal:  Eurasian J Med       Date:  2019-10

7.  Methylglyoxal as a novel signal molecule induces the salt tolerance of wheat by regulating the glyoxalase system, the antioxidant system, and osmolytes.

Authors:  Zhong-Guang Li; Xiang-Qiu Duan; Xiong Min; Zhi-Hao Zhou
Journal:  Protoplasma       Date:  2017-03-09       Impact factor: 3.356

8.  The role of endothelial cell adhesion molecules P-selectin, E-selectin and intercellular adhesion molecule-1 in leucocyte recruitment induced by exogenous methylglyoxal.

Authors:  Yang Su; Xi Lei; Lingyun Wu; Lixin Liu
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

9.  Smooth muscle-generated methylglyoxal impairs endothelial cell-mediated vasodilatation of cerebral microvessels in type 1 diabetic rats.

Authors:  Fadhel Alomar; Jaipaul Singh; Hee-Seong Jang; George J Rozanzki; Chun Hong Shao; Babu J Padanilam; William G Mayhan; Keshore R Bidasee
Journal:  Br J Pharmacol       Date:  2016-10-14       Impact factor: 8.739

10.  Up-regulation of aldolase A and methylglyoxal production in adipocytes.

Authors:  Jianghai Liu; Kaushik Desai; Rui Wang; Lingyun Wu
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.